OTC: NIMU
NON INVASIVE MONITORING SYSTEMS INC /FL/CIK 0000720762 · SIC 3760 · Guided Missiles & Space Vehicles
Non-Invasive Monitoring Systems, Inc. (together with its consolidated subsidiaries, the “Company,” “NIMS,” “we,” “us” or “our”) was incorporated under the laws of the State of Florida on July 16, 1980. The Company’s offices are located at 4400 Biscayne Boulevard, Miami, Florida, 33137 and its… About this business →
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (SRBK 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade NIMU commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
NIMU sets $15.50 IPO price, $125M raise; merger terms revised to 96.5% Gravitics ownership
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(In thousands, except share and per share data)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Operating costs and expenses | ||||
| General and administrative | 261 | 26 | 404 | 49 |
| Total operating costs and expenses | 261 | 26 | 404 | 49 |
| Operating loss | (261) | (26) | (404) | (49) |
| Interest expense related parties | (23) | (16) | (43) | (32) |
| Net loss | (284) | (42) | (447) | (81) |
| Weighted average number of common shares outstanding Basic and diluted | 1,032,640 | 1,032,640 | 1,032,640 | 1,032,640 |
| Basic and diluted loss per common share | (0.28) | (0.04) | (0.43) | (0.08) |
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
| Description | June 30, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash | 160 | 6 |
| Prepaid expenses | 4 | - |
| Total current assets | 164 | 6 |
| Total assets | 164 | 6 |
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | 304 | 142 |
| Current liabilities discontinued operations | 51 | 51 |
| Notes payable related parties | 300 | 620 |
| Convertible note | 810 | - |
| Notes Payable accrued interest | 142 | 189 |
| Total current liabilities | 1,607 | 1,002 |
| Total liabilities | 1,607 | 1,002 |
| Commitments and contingencies | ||
| Shareholders’ deficit | ||
| Series B Preferred Stock, par value $1.00 per share; 100 shares authorized, issued and outstanding; liquidation preference $10 | - | - |
| Common Stock, par value $0.01 per share; 400,000,000 shares authorized; 1,032,640 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | 10 | 10 |
| Additional paid in capital | 28,112 | 28,112 |
| Accumulated deficit | (29,565) | (29,118) |
| Total shareholders’ deficit | (1,443) | (996) |
| Total liabilities and shareholders’ deficit | 164 | 6 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Operating activities | ||
| Net loss | (447) | (81) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Changes in operating assets and liabilities | ||
| Prepaid expenses | (4) | 9 |
| Accounts payable and accrued expenses | 161 | (8) |
| Accrued interest | (46) | 32 |
| Net cash used in operating activities | (336) | (48) |
| Financing Activities | ||
| Proceeds from notes payable related party | 400 | 40 |
| Proceeds from convertible note | 810 | - |
| Payment of notes payable | (720) | - |
| Net cash provided by financing activities | 490 | 40 |
| Net increase (decrease) in cash | 154 | (8) |
| Cash, beginning of period | 6 | 11 |
| Cash, end of period | 160 | 3 |
Amounts as printed on the EDGAR/iXBRL face — (In thousands, except share and per share data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗
About NON INVASIVE MONITORING SYSTEMS INC /FL/
Source: Item 1 (Business) from the 10-K filed January 30, 2026. Description as filed by the company with the SEC.
Item
1. Business.
General
Non-Invasive
Monitoring Systems, Inc. (together with its consolidated subsidiaries, the “Company,” “NIMS,” “we,”
“us” or “our”) was incorporated under the laws of the State of Florida on July 16, 1980. The Company’s
offices are located at 4400 Biscayne Boulevard, Miami, Florida, 33137 and its telephone number is (305) 575-4200.
Company
Overview
Our
primary business previously consisted of research, development, manufacturing, marketing and sales of non-invasive, motorized, whole
body periodic acceleration (“WBPA”) platforms. These therapeutic acceleration platforms are intended as aids to temporarily
increase local circulation for temporary relief of minor aches and pains, produce local muscle relaxation and reduce morning stiffness.
In
May 2019, we effectively discontinued operations. The Company is a shell company as defined in Rule 12b-2 of the Exchange Act.
Products
We
currently have no inventory and do not have any of our products available for sale.